Federal award
KBR WYLE SERVICES, LLC
0040
Contract
Obligated and Ceiling
- Obligated (net)
- $23,547,678.01
- Ceiling (potential value, not spending)
- $23,262,035.04
- Current value
- $23,262,035.04
- Gross positive obligations
- $26,854,973.80
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · PMRAPK4NLQC1
- Owner company
- KBRBasis reported by USAspending: the recipient reports this company as its parent; ownership is not reviewed.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of War · sub-agency 2100 · office W31P4Q
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- R408 · SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT
- Industry (NAICS)
- 541330 · ENGINEERING SERVICES
- PIID
- 0040
- Parent vehicle (IDV PIID)
- W31P4Q05A0024
- Award type code
- C
- Actions
- 60 · Mar 24, 2011 to Apr 18, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History60
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 18, 2020 | FY2020 | 55 | K | $0.00 | |
| Jan 24, 2020 | FY2020 | 54 | M | −$506,716.23 | |
| Sep 30, 2019 | FY2019 | 53 | M | −$221,691.83 | |
| Sep 30, 2019 | FY2019 | 53 | M | −$11,891.62 | |
| Jul 27, 2018 | FY2018 | 52 | C | −$30,262.18 | |
| Jul 18, 2018 | FY2018 | 51 | B | $0.00 | |
| Jan 29, 2018 | FY2018 | 50 | C | −$5,224.22 | |
| Sep 28, 2017 | FY2017 | 49 | D | −$8,118.61 | |
| Jul 12, 2017 | FY2017 | 48 | B | −$14,613.94 | |
| Jul 12, 2017 | FY2017 | 48 | B | −$113,255.37 | |
| Sep 28, 2016 | FY2016 | 47 | D | −$27,544.37 | |
| Oct 13, 2015 | FY2016 | 46 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 1, 2015 | FY2015 | 45 | D | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 18, 2015 | FY2015 | 44 | D | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 2, 2015 | FY2015 | 43 | D | $36,997.58 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 19, 2015 | FY2015 | 42 | G | $3,846,318.86 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 19, 2015 | FY2015 | 42 | G | $275,150.95 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 12, 2015 | FY2015 | 41 | D | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Oct 3, 2014 | FY2015 | 40 | D | −$1,436,250.65 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 25, 2014 | FY2014 | 39 | G | $57,865.04 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 27, 2014 | FY2014 | 38 | B | −$60,338.11 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 24, 2014 | FY2014 | 37 | G | $5,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 11, 2014 | FY2014 | 36 | G | $60,240.48 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 21, 2014 | FY2014 | 35 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 17, 2014 | FY2014 | 34 | G | $44,537.40 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 21, 2014 | FY2014 | 33 | G | $5,337,350.97 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 18, 2014 | FY2014 | 32 | D | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 27, 2014 | FY2014 | 31 | D | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 13, 2013 | FY2014 | 30 | G | $40,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 28, 2013 | FY2013 | 29 | G | $25,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 24, 2013 | FY2013 | 28 | G | $62,034.84 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 16, 2013 | FY2013 | 27 | B | −$37.02 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 12, 2013 | FY2013 | 26 | G | $97,776.32 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 7, 2013 | FY2013 | 25 | G | $118,134.62 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 22, 2013 | FY2013 | 24 | G | $4,378,642.58 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 31, 2012 | FY2013 | 23 | G | $94,938.86 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 6, 2012 | FY2013 | 22 | G | $55,979.83 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 19, 2012 | FY2013 | 21 | G | $82,445.68 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Oct 18, 2012 | FY2013 | 20 | G | $78,169.95 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 18, 2012 | FY2012 | 19 | G | $48,112.44 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 14, 2012 | FY2012 | 18 | G | $32,737.68 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 4, 2012 | FY2012 | 17 | G | $1,764,330.42 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 24, 2012 | FY2012 | 16 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 13, 2012 | FY2012 | 15 | G | $73,940.80 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 12, 2012 | FY2012 | 14 | G | $225,827.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 25, 2012 | FY2012 | 13 | G | $64,748.80 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 10, 2012 | FY2012 | 12 | G | $176,953.60 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 23, 2012 | FY2012 | 11 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 7, 2012 | FY2012 | 10 | G | $3,333,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 17, 2012 | FY2012 | 9 | G | $62,351.20 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 19, 2012 | FY2012 | 8 | G | $75,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 11, 2012 | FY2012 | 7 | G | $37,948.48 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 6, 2012 | FY2012 | 6 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 20, 2011 | FY2012 | 5 | G | $871,351.64 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 10, 2011 | FY2012 | 4 | D | −$871,351.64 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 20, 2011 | FY2011 | 3 | G | $124,052.48 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 30, 2011 | FY2011 | 2 | G | $141,906.40 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 11, 2011 | FY2011 | 1 | G | $228,732.71 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 24, 2011 | FY2011 | 0 | — | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 24, 2011 | FY2011 | 0 | — | $4,897,396.19 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.